The U.S. BPH surgical treatment market was valued at USD 714.48 million in 2024 and is projected to grow at a CAGR of 5.6% from 2025 to 2034. Segmentation by procedure type and care setting reveals nuanced dynamics in product differentiation, application‑specific growth, and value chain optimization. TURP remains the cornerstone procedure, but minimally invasive techniques like PUL, laser...